Advertisement
News
Subscribe to MDT Magazine News

Mylan Launches Generic Version of Risperdal® M-Tab®

May 13, 2011 4:47 am | by Bio-Medicine.Org | Comments

PITTSBURGH, May 13, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Risperidone Orally Disintegrating Tablets (ODT), 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg, the generic version of Ortho-McNeil's Risperdal® M-Tab®, a...

Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)

May 13, 2011 4:45 am | by Bio-Medicine.Org | Comments

NEWPORT NEWS, Va., May 13, 2011 /- The possibility of low-dose Molecular Breast Imaging (MBI) looks promising according to the most recent clinical evidence revealed this past month at the National Institutes of Health (NIH). Dr. Marcela Bohm-Velez and her colleagues from Associates in...

TOPICS:

Sinovac posts larger 1Q loss as costs increase

May 13, 2011 3:45 am | by The Associated Press | Comments

Chinese vaccine maker Sinovac Biotech Ltd. reported a larger first-quarter loss Friday, with rising expenses more than offsetting slight improvements in its revenue.Sinovac reported a net loss of $2.1 million, or 5 cents per share, in the three months ended March 31 versus a net loss of...

Advertisement

Winner Medical to Present at Oppenheimer 5th Annual China Dragon Conference

May 13, 2011 2:47 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, May 13, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced it will attend...

TOPICS:

Novel Device Shows Promise for Reducing HIV Among Men

May 12, 2011 11:36 am | by Bio-Medicine.Org | Comments

NEW YORK, May 12, 2011 /PRNewswire-USNewswire/ -- Promising study results published in the May issue of JAIDS show that a novel medical device has the potential to revolutionize how male circumcision services are offered in countries hardest hit by the HIV epidemic. Conducted by...

TOPICS:

Diopsys, Inc. Launches New Website for Doctors and Patients, www.Diopsys.com

May 12, 2011 11:36 am | by Bio-Medicine.Org | Comments

PINE BROOK, N.J., May 12, 2011 /- Diopsys, Inc. launched its new website – www.diopsys.com - that showcases the company's growing product line and vision for the future. The new website features expanded product information, educational resources for physicians and patients, as well...

TOPICS:

Cornerstone Therapeutics 1Q profit, sales tumble

May 12, 2011 10:45 am | by The Associated Press | Comments

Cornerstone Therapeutics Inc. said Thursday its first-quarter net income tumbled 65 percent, as sales for its HyoMax product family and other products fell.The Cary, N.C., company earned $1.7 million, or 7 cents per share, in the three months ended March 31. That compares with earnings of $5...

MindChild Medical finds funding for monitors

May 12, 2011 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

MindChild Medical Inc., a North Andover startup making a fetal heart monitor to measure the health of unborn babies, has raised $373,594 of a planned $500,000 funding, according to federal documents.

Advertisement

Lytton joins fellow ex-Biogen exec Mullen at Patheon

May 12, 2011 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Former Biogen Idec EVP Michael Lytton is joining former Biogen CEO Jim Mullen in Toronto to help lead Patheon Inc., a pharmaceutical contract development and manufacturing services firm.

InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India

May 12, 2011 10:34 am | by Bio-Medicine.Org | Comments

TEL AVIV, Israel, May 12, 2011 /- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard ™ mesh protective stent system, is happy to announce that MGuard is now available in India. MGuard, InspireMD's flagship product is India's first mesh-based...

TOPICS:

Kinetic Concepts subsidiary gets FDA warning

May 12, 2011 8:45 am | by The Associated Press | Comments

Medical technology company Kinetic Concepts Inc. said Thursday that Food and Drug Administration is dissatisfied with the response it has gotten from its LifeCell Corp. subsidiary following a government inspection in November of LifeCell-sponsored clinical studies.The FDA also identified...

Consumer Information on: RX Acculink Carotid Stent System - P040012/S034

May 12, 2011 8:39 am | by U.S. Food & Drug Administration | Comments

The RX Acculink Carotid Stent System consists of the Acculink self-expanding carotid stent mounted on the Rapid Exchange (RX) delivery system and is used to re-open narrowed (stenotic) regions of the carotid arteries in the neck which supply blood to...

Exclusive Coverage for Kidney Dialysis Centers Offered by Five Star Healthcare

May 12, 2011 8:39 am | by Bio-Medicine.Org | Comments

SACRAMENTO, Calif., May 12, 2011 /- Five Star Healthcare™, a division of Crump Insurance Services, Inc., and part of Crump Group, Inc., the nation's largest insurance wholesaler, today announced it has added a new insurance facility for Kidney Dialysis Centers. The program, offered...

TOPICS:

Dr. Dorla Mirejovsky Joins Irvine Pharmaceutical Services as Senior Director of Formulation Development

May 12, 2011 8:39 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., May 12, 2011 /- Irvine Pharmaceutical Services is excited to announce the addition of Dr. Dorla Mirejovsky, as the Senior Director of Formulation Development.  Dr. Mirejovsky brings with her over 25 years of experience in pharmaceutical development, drug delivery, and...

TOPICS:

Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052)

May 12, 2011 8:38 am | by Bio-Medicine.Org | Comments

WASHINGTON, May 12, 2011 /PRNewswire-USNewswire/ -- Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners through initiation of oral antiretroviral therapy (ART), according to findings from a large multinational clinical study conducted by the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading